Long COVID: The latest manifestations, mechanisms, and potential therapeutic interventions
Abstract COVID‐19 caused by SARS‐CoV‐2 infection affects humans not only during the acute phase of the infection, but also several weeks to 2 years after the recovery. SARS‐CoV‐2 infects a variety of cells in the human body, including lung cells, intestinal cells, vascular endothelial cells, olfacto...
| Published in: | MedComm |
|---|---|
| Main Authors: | Shi‐ting He, Kexin Wu, Zixuan Cheng, Mengjie He, Ruolan Hu, Ning Fan, Lin Shen, Qirui Li, Huahao Fan, Yigang Tong |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-12-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1002/mco2.196 |
Similar Items
Panorama of Breakthrough Infection Caused by SARS-CoV-2: A Review
by: Qinglu Fan, et al.
Published: (2022-11-01)
by: Qinglu Fan, et al.
Published: (2022-11-01)
On the SARS-CoV-2 Variants
by: Fabio Scarpa, et al.
Published: (2024-03-01)
by: Fabio Scarpa, et al.
Published: (2024-03-01)
SARS-CoV-2 and Coronaviruses: Understanding Transmission, Impact, and Strategies for Prevention and Treatment
by: Seyede Nafise Tabatabaei, et al.
Published: (2025-02-01)
by: Seyede Nafise Tabatabaei, et al.
Published: (2025-02-01)
Trends in Antibody Titers after SARS-CoV-2 Vaccination—Insights from Self-Paid Tests at a General Internal Medicine Clinic
by: Hiroshi Kusunoki, et al.
Published: (2023-04-01)
by: Hiroshi Kusunoki, et al.
Published: (2023-04-01)
Increase in antibody titer and change over time associated with severe acute respiratory syndrome coronavirus 2 infection after mRNA vaccination: Consideration of the significance of additional vaccination
by: Hiroshi Kusunoki, et al.
Published: (2024-06-01)
by: Hiroshi Kusunoki, et al.
Published: (2024-06-01)
COVID-19 and the COVID-19 Vaccine in Japan—A Review from a General Physician’s Perspective
by: Hiroshi Kusunoki
Published: (2023-06-01)
by: Hiroshi Kusunoki
Published: (2023-06-01)
Longitudinal Changes in IgG-Type SARS-CoV-2 Antibody Titers after COVID-19 Vaccination and a Prominent Increase in Antibody Titers When Infected after Vaccination
by: Hiroshi Kusunoki, et al.
Published: (2023-04-01)
by: Hiroshi Kusunoki, et al.
Published: (2023-04-01)
SARS-CoV-2: Searching for the Missing Variants
by: Emilia Caputo, et al.
Published: (2022-10-01)
by: Emilia Caputo, et al.
Published: (2022-10-01)
Structural and Phylogenetic Analysis of SARS-CoV-2 Spike Glycoprotein from the Most Widespread Variants
by: Emilia Caputo, et al.
Published: (2022-08-01)
by: Emilia Caputo, et al.
Published: (2022-08-01)
Unpacking the Implications of SARS-CoV-2 Breakthrough Infections on COVID-19 Vaccination Programs
by: Tafadzwa Dzinamarira, et al.
Published: (2022-02-01)
by: Tafadzwa Dzinamarira, et al.
Published: (2022-02-01)
Genomic profiles of vaccine breakthrough SARS-CoV-2 strains from Odisha, India
by: Arup Ghosh, et al.
Published: (2022-06-01)
by: Arup Ghosh, et al.
Published: (2022-06-01)
Common Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant
by: Ravi Kant, et al.
Published: (2021-11-01)
by: Ravi Kant, et al.
Published: (2021-11-01)
Assessment of the Biological Impact of SARS-CoV-2 Genetic Variation Using an Authentic Virus Neutralisation Assay with Convalescent Plasma, Vaccinee Sera, and Standard Reagents
by: Naomi S. Coombes, et al.
Published: (2023-02-01)
by: Naomi S. Coombes, et al.
Published: (2023-02-01)
COVID-19 Breakthrough Infections and Transmission Risk: Real-World Data Analyses from Germany’s Largest Public Health Department (Cologne)
by: Lea Hsu, et al.
Published: (2021-11-01)
by: Lea Hsu, et al.
Published: (2021-11-01)
Association between virus variants, vaccination, previous infections, and post-COVID-19 risk
by: Sophie Diexer, et al.
Published: (2023-11-01)
by: Sophie Diexer, et al.
Published: (2023-11-01)
Detection of SARS-CoV-2 Variants via Different Diagnostics Assays Based on Single-Nucleotide Polymorphism Analysis
by: Eliana Specchiarello, et al.
Published: (2023-04-01)
by: Eliana Specchiarello, et al.
Published: (2023-04-01)
Impact of vaccination and variants of concern on long COVID clinical phenotypes
by: Grace Kenny, et al.
Published: (2023-11-01)
by: Grace Kenny, et al.
Published: (2023-11-01)
Effect of Vaccination against SARS-CoV-2 on Long COVID-19: A Narrative Review
by: Andreas G. Tofarides, et al.
Published: (2022-12-01)
by: Andreas G. Tofarides, et al.
Published: (2022-12-01)
Effectiveness of COVID-19 Vaccines against Delta (B.1.617.2) Variant: A Systematic Review and Meta-Analysis of Clinical Studies
by: Ali Pormohammad, et al.
Published: (2021-12-01)
by: Ali Pormohammad, et al.
Published: (2021-12-01)
Comparison of Immunological Profiles of SARS-CoV-2 Variants in the COVID-19 Pandemic Trends: An Immunoinformatics Approach
by: Jenifer Mallavarpu Ambrose, et al.
Published: (2021-05-01)
by: Jenifer Mallavarpu Ambrose, et al.
Published: (2021-05-01)
SARS-CoV-2 Vaccine Breakthrough Reinfections in Fully Vaccinated Healthcare Workers in Davao City, Philippines: A Retrospective Cohort Study
by: Alfredo A. Hinay, et al.
Published: (2025-07-01)
by: Alfredo A. Hinay, et al.
Published: (2025-07-01)
Characteristics of COVID-19 Breakthrough Infections among Vaccinated Individuals and Associated Risk Factors: A Systematic Review
by: Shilpa Gopinath, et al.
Published: (2022-05-01)
by: Shilpa Gopinath, et al.
Published: (2022-05-01)
RT-PCR Detection of SARS-CoV-2 among Individuals from the Upper Silesian Region—Analysis of 108,516 Tests
by: Adam Konka, et al.
Published: (2021-12-01)
by: Adam Konka, et al.
Published: (2021-12-01)
Development of SARS-CoV-2 entry antivirals
by: Meiyue Dong, et al.
Published: (2024-02-01)
by: Meiyue Dong, et al.
Published: (2024-02-01)
Emergence of Two Distinct SARS-CoV-2 Gamma Variants and the Rapid Spread of P.1-like-II SARS-CoV-2 during the Second Wave of COVID-19 in Santa Catarina, Southern Brazil
by: Dayane Azevedo Padilha, et al.
Published: (2022-03-01)
by: Dayane Azevedo Padilha, et al.
Published: (2022-03-01)
Interaction of SARS-CoV-2 and SARS-CoV-2 vaccines with renin angiotensin aldosterone system, clinical outcomes, and angiotensin (1-7) as a physiological treatment recommendation: hypothesis and theory article
by: Ali Rıza Aktaş
Published: (2025-07-01)
by: Ali Rıza Aktaş
Published: (2025-07-01)
Risk of paediatric multisystem inflammatory syndrome (PIMS-TS) during the SARS-CoV-2 alpha and delta variant waves: National observational and modelling study, 2020–21, England
by: Joseph Shingleton, et al.
Published: (2022-12-01)
by: Joseph Shingleton, et al.
Published: (2022-12-01)
Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study
by: Chuancai Xu, et al.
Published: (2022-11-01)
by: Chuancai Xu, et al.
Published: (2022-11-01)
Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections
by: Iris Medits, et al.
Published: (2022-07-01)
by: Iris Medits, et al.
Published: (2022-07-01)
Protection of Prior SARS-CoV-2 Infection Against Different Variants, Including Omicron Descendants, in a Country with High Viral Transmission
by: Stefan Escobar-Agreda, et al.
Published: (2025-05-01)
by: Stefan Escobar-Agreda, et al.
Published: (2025-05-01)
In Silico Design of Peptide-Based SARS-CoV-2 Fusion Inhibitors That Target WT and Mutant Versions of SARS-CoV-2 HR1 Domains
by: Shana V. Stoddard, et al.
Published: (2021-07-01)
by: Shana V. Stoddard, et al.
Published: (2021-07-01)
Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern
by: Abdul Aziz Al-Fattah Yahaya, et al.
Published: (2023-02-01)
by: Abdul Aziz Al-Fattah Yahaya, et al.
Published: (2023-02-01)
Sustained applicability of SARS-CoV-2 variants identification by Sanger Sequencing Strategy on emerging various SARS-CoV-2 Omicron variants in Hiroshima, Japan
by: Chanroth Chhoung, et al.
Published: (2024-11-01)
by: Chanroth Chhoung, et al.
Published: (2024-11-01)
Recommendations for Uniform Variant Calling of SARS-CoV-2 Genome Sequence across Bioinformatic Workflows
by: Ryan Connor, et al.
Published: (2024-03-01)
by: Ryan Connor, et al.
Published: (2024-03-01)
The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
by: Yun-yu Zhang, et al.
Published: (2020-08-01)
by: Yun-yu Zhang, et al.
Published: (2020-08-01)
SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)
by: T.M. Abdelghany, et al.
Published: (2021-03-01)
Impact of vaccination on kinetics of neutralizing antibodies against SARS-CoV-2 by serum live neutralization test based on a prospective cohort
by: Liguo Zhu, et al.
Published: (2023-12-01)
by: Liguo Zhu, et al.
Published: (2023-12-01)
A Pre-Vaccination Baseline of SARS-CoV-2 Genetic Surveillance and Diversity in the United States
by: Adam A. Capoferri, et al.
Published: (2022-01-01)
by: Adam A. Capoferri, et al.
Published: (2022-01-01)
Viral Etiological Agent(s) of Respiratory Tract Infections in Symptomatic Individuals during the Second Wave of COVID-19 Pandemic: A Single Drive-Thru Mobile Collection Site Study
by: Aleksandra Kozinska, et al.
Published: (2022-04-01)
by: Aleksandra Kozinska, et al.
Published: (2022-04-01)
SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers
by: Elisa Regenhardt, et al.
Published: (2023-05-01)
by: Elisa Regenhardt, et al.
Published: (2023-05-01)
Similar Items
-
Panorama of Breakthrough Infection Caused by SARS-CoV-2: A Review
by: Qinglu Fan, et al.
Published: (2022-11-01) -
On the SARS-CoV-2 Variants
by: Fabio Scarpa, et al.
Published: (2024-03-01) -
SARS-CoV-2 and Coronaviruses: Understanding Transmission, Impact, and Strategies for Prevention and Treatment
by: Seyede Nafise Tabatabaei, et al.
Published: (2025-02-01) -
Trends in Antibody Titers after SARS-CoV-2 Vaccination—Insights from Self-Paid Tests at a General Internal Medicine Clinic
by: Hiroshi Kusunoki, et al.
Published: (2023-04-01) -
Increase in antibody titer and change over time associated with severe acute respiratory syndrome coronavirus 2 infection after mRNA vaccination: Consideration of the significance of additional vaccination
by: Hiroshi Kusunoki, et al.
Published: (2024-06-01)
